SSY Group (02005) is expected to win the bid for 45 product varieties in the national centralized procurement continuation.

16:33 10/02/2026

China National Pharmaceutical Group (02005) announced that in the follow-up procurement of the first to eighth batches of centralized national drug procurement on February 10, 2026, a total of 45 products from the group are expected to win bids, covering areas such as anti-infection, cardiovascular system, respiratory system, digestive system, and nervous system, which are expected to have a positive impact on the group's business.

SSY Group (02005) announced that in the continuation of the first to eighth batches of national drug centralized procurement (national procurement) in China on February 10, 2026, the Group has proposed to win the bid for 45 product varieties, covering the treatment areas of anti-infection, cardiovascular system, respiratory system, digestive system, nervous system, etc., which is expected to have a positive impact on the Group's business.

PRU (02378) spent GBP 4.5265 million on February 9 to buy back 38,400 shares.

Shiyue Daotian (09676) spent 4.0316 million Hong Kong dollars on February 10 to repurchase 450,000 shares.

CR BLDG MAT TEC(01313): Li Nan appointed as a member of the nomination committee.

PRU (02378) spent GBP 4.5265 million on February 9 to buy back 38,400 shares.

Shiyue Daotian (09676) spent 4.0316 million Hong Kong dollars on February 10 to repurchase 450,000 shares.

CR BLDG MAT TEC(01313): Li Nan appointed as a member of the nomination committee.